openPR Logo
Press release

Gastrointestinal Stents Market Size Expected to Reach US$ 1,201.5 Million by 2035: Fact.MR Report

05-02-2025 09:08 AM CET | Health & Medicine

Press release from: Fact.MR

Gastrointestinal Stents Market

Gastrointestinal Stents Market

The global gastrointestinal stents market is expected to rise steadily during the forthcoming decade, from an approximate value of USD 567.8 million in 2025 to USD 1,201.5 million in 2035, at a robust CAGR of 7.8%.

This is driven by the global increase in gastrointestinal disorders, the growing need for minimally invasive procedures, and the aging populations with an increased susceptibility towards gastrointestinal complications. They are becoming the norm in endoscopic treatment methods, offering non-operative interventions for the treatment of malignant and benign gastrointestinal tract obstructions.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7694

Country-wise Analysis

The USA gastrointestinal stents market will advance at 6.3% CAGR during the study period. The USA gastrointestinal stents market will increase gradually with the high prevalence of gastrointestinal cancers and the rigid adherence to minimum invasive surgical practices. Advanced healthcare units and the rapid adoption of next-generation stents such as biodegradable and drug-eluting stents keep propelling the sales penetration.

The UK gastrointestinal stents market is likely to expand at 5.6% CAGR over the study period. In the UK, the gastrointestinal stents market is increasing in popularity because of increased cases of colorectal and esophageal cancer, and increased dependence on endoscopic treatments for palliative care.

France's market for gastrointestinal stents will expand at 5.3% CAGR during the forecast period. France is likely to witness sluggish growth in the market for gastrointestinal stents, aided by a keen awareness of digestive tract cancer and widespread use of endoscopic diagnostics. Active screening by the public health system for gastric and colorectal cancers enables early detection and timely stent intervention.

Japan's stents market in the gastrointestinal arena is expected to grow at a 5.2% CAGR during the study. The market for Japan's gastrointestinal stents is set to grow consistently, driven by Japan's increased incidence of gastrointestinal cancers and well-equipped hospital infrastructure. Palliative stenting to treat obstructive gastrointestinal tumors is well established in older individuals.

Segment-wise Analysis

According to Stent Type

By stent type, the gastrointestinal stents market is divided into metal stents, which will account for 69.1%, and plastic stents will account for 30.9%.

By Product

Biliary stents will capture 31.4% of the market in 2025, and esophageal stents will capture 24.2% of the gastrointestinal stents market.

Competitive Outlook

The gastrointestinal stents market is technologically advanced, device miniaturized, and increasingly characterized by a preference for minimally invasive treatments. An alliance of global MedTech giants and local specialist companies defines industry dynamics. Though competition is driven by product reliability and regulatory compliance, manufacturers differentiate based on real-time imaging compatibility and anti-migration designs, in addition to former drivers, as an answer to complex clinical needs in palliative and curative GI interventions.

The top players are Boston Scientific Corporation, Cook Medical, and Taewoong Medical Co. Ltd. They are leaders in the gastrointestinal stents market because of their innovation pipelines and array of stents available. Boston Scientific leadership comes from advanced covered metal stents with drug-eluting capabilities, whereas Cook Medical is concentrating on dual-layer constructs to enhance flexibility and patient comfort. Taewoong, known for design precision, continues to expand globally with customized solutions for biliary, duodenal, and esophageal conditions.

Becton, Dickinson and Company (through C.R. Bard Inc.), and Olympus Corporation have become competitive by combining stent technology with tools of endoscopic visualization. BD combines smooth delivery systems for ease of optimal placement, while Olympus utilizes endoscopy expertise to facilitate stent placement with high procedural accuracy. Both focus on procedural efficiency in outpatient and low-resource environments.

Browse Full Report: https://www.factmr.com/report/gastrointestinal-stents-market

Key Players

Boston Scientific Corporation
Becton, Dickinson and Company
C.R. Bard Inc.
W.L. Gore & Associates Inc.
Cook Medical
Taewoong Medical Co. Ltd.
Merit Medical Systems Inc.
ELLA-CS, s.r.o
CONMED Corporation
Olympus Corporation
S&G Biotech Inc
Other regional and endoscopic device firms

Segmentation

By Stent Type:
Metal Stents
Plastic Stents
By Product:
Biliary Stents
Duodenal Stents
Colonic Stents
Pancreatic Stents
Esophageal Stents
By End User:
Hospitals
Clinics
Ambulatory Surgery Centers
Others
By Region:
North America
Latin America
Europe
East Asia
South Asia & Oceania
Middle East and Africa (MEA)

Check out More Related Studies Published by Fact.MR:

3D Dental Scanners Market
https://www.factmr.com/report/3d-dental-scanners-market
Ulcerative Colitis Therapeutics Market
https://www.factmr.com/report/ulcerative-colitis-therapeutics-market
Viral Antigens Market
https://www.factmr.com/report/1305/viral-antigens-market
Peripheral Vascular Devices Market
https://www.factmr.com/report/peripheral-vascular-devices-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastrointestinal Stents Market Size Expected to Reach US$ 1,201.5 Million by 2035: Fact.MR Report here

News-ID: 3996670 • Views:

More Releases from Fact.MR

Organic Rice Syrup Market is forecasted to increase at a CAGR of 5.1% and US$ 1.36 billion by 2034
02-27-2026 | Food & Beverage
Fact.MR
Organic Rice Syrup Market is forecasted to increase at a CAGR of 5.1% and US$ 1. …
The global Organic Rice Syrup Market is projected to expand steadily over the coming decade, driven by rising consumer demand for natural, clean-label sweeteners and growing awareness of health and wellness trends. Industry analysts estimate that the organic rice syrup market, valued at approximately USD 450 million in 2025, is expected to reach nearly USD 880 million by 2035, registering a compound annual growth rate (CAGR) of about 7.1% during
Compound Horse Feedstuff Market is Estimated to Grow at a CAGR of 4.6%, Reaching USD 13.9 billion by 2035
02-27-2026 | Food & Beverage
Fact.MR
Compound Horse Feedstuff Market is Estimated to Grow at a CAGR of 4.6%, Reaching …
The global compound horse feedstuff market is galloping toward steady growth, projected to expand from a valuation of USD 3.8 billion in 2026 to approximately USD 5.4 billion by 2036. This represents a compound annual growth rate (CAGR) of 3.6% over the ten-year forecast period. The market is being driven by the "humanization" of equine companions, the professionalization of equestrian sports, and a significant shift toward specialized performance nutrition that
Nutritional Yeast Market Forecasted CAGR is 7.1% by 2035 | Fact.MR Report
02-27-2026 | Food & Beverage
Fact.MR
Nutritional Yeast Market Forecasted CAGR is 7.1% by 2035 | Fact.MR Report
The global nutritional yeast market is experiencing a significant surge in demand, projected to grow from a valuation of USD 515.2 million in 2026 to approximately USD 1.2 billion by 2036. This represents a robust compound annual growth rate (CAGR) of 8.8% over the ten-year forecast period. The market is being propelled by the global explosion of plant-based diets and the "clean-label" movement, with nutritional yeast emerging as the primary
Dairy Stabilizer Market is Expected to Reach USD 1,420.0 million by 2035 | Research Report by Fact.MR
02-27-2026 | Food & Beverage
Fact.MR
Dairy Stabilizer Market is Expected to Reach USD 1,420.0 million by 2035 | Resea …
The global Dairy Stabilizers Market is projected to sustain solid growth over the next decade as consumer demand for high-quality dairy and dairy-based products continues to expand across foodservice and retail sectors. Industry analysts estimate that the dairy stabilizers market, valued at approximately USD 2.4 billion in 2025, is expected to reach around USD 4.3 billion by 2035, registering a compound annual growth rate (CAGR) of about 6.5% during the

All 5 Releases


More Releases for Stent

Airway Stent/Lung Stent Market: Opportunities for Future Expansion
Airway Stent/Lung Stent Market valued at USD X.X Billion in 2024 and is projected to reach USD X.X Billion by 2032, growing at a CAGR of X.X% from 2025 to 2032. What is the Airway Stent/Lung Stent Market and Why is It Significant? The Airway Stent/Lung Stent market involves the production and distribution of medical devices designed to support and keep open airways in patients suffering from conditions such as tracheal stenosis,
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lung
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on an
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients